The Fresh Start Private Experience

Fresh Start Private (FSP) and its unique treatment program offer those suffering with alcoholism a far greater opportunity for total recovery as compared to traditional alcohol treatment centers.*
To date, more than 1,600 patients have received the FSP naltrexone implant** in Australia. The Australian Therapeutics Goods Administration has found the FSP naltrexone formulation and implant procedure to be safe and effective**. This biodegradable single-administration, long-acting naltrexone implant procedure is the only naltrexone implant for the treatment of alcohol addiction in the world that has been approved for use by a regulatory body.
By allowing a patient to significantly reduce his or her cravings and desire for alcohol for an average of approximately 200 days and up to as many as 390 days***, FSP offers an unprecedented opportunity for success and complete recovery. We have combined this innovative medical intervention procedure with the On-Purpose® Fresh Start Coaching Program, the Family and Friends Rebuilding Program & Retreat, and the Continuing Care program, to create what we believe is the most effective, most comprehensive alcohol treatment program available today. The FSP program provides all patients complete anonymity and confidentiality.
FSP is now pleased to invite patients in the United States to experience this unique, next-generation program in Australia.
Please take a moment to review the testimonials of several patients that have had the joy of regaining their lives following the implant procedure.
* FSP does not render medical advice or services. Individuals should consult their physicians or other competent medical professionals to determine if FSP's program is right for them. Medical services in Australia are provided by Dr. George O’Neil and physicians working with him.
** The FSP naltrexone formulation and the implant procedure have been approved as safe and effective under the Special Access Scheme by the Australian Therapeutics Goods Administration. The FSP naltrexone formulation and the implant procedure have not been approved by the FDA. Treatment with the FSP naltrexone formulation and the implant procedure is not available in the United States.*** Addiction Biology (March 2004) 8, 65-70. G.K. Husle, D.E. Arnold-Reed. G. O'Neil, C-T. Chan & R.C. Hansson






